NewCo 2.0 Transaction Sample: The Report of a US Veteran Fund
How K2 reshapes Newco ecosystem
Time：
2026-07-17 08:11
Author：
xieyijun
CPIC 2026 l 800+ Speakers from 22 Countries! Who are the overseas guests?
The detailed list has arrived! Let's go 1v1 in advance
Time：
2026-07-14 08:33
Author：
xieyijun
AI Drug Discovery, New Tracks Emerge
Virtual Cells Gaining Momentum
Time：
2026-07-12 08:47
Author：
xieyijun
CPIC 2026丨Global Innovation of Antibodies and ADCs session
16 keynote speakers discuss the future of antibody drug innovation
Time：
2026-07-11 08:48
Author：
xieyijun
Drug Development, Dreaming of Space
There is still a significant gap between being able to experiment and being able to make drugs
Time：
2026-07-11 08:39
Author：
xieyijun
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务